HSPG2 and chronic obstructive pulmonary disease: Challenge with AA (100 μM) resulted in a reduced basal deposition of all ECM proteins measured (fibronectin, tenascin, type I collagen and perlecan) in COPD fibroblasts (n = 5–7) (p < 0.05).